Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities

Vaccination is a key component of public health policy with demonstrated cost-effective benefits in protecting both human and animal populations. Vaccines can be manufactured under multiple forms including, inactivated (killed), toxoid, live attenuated, Virus-like Particles, synthetic peptide, polys...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghattas, Majed, Dwivedi, Garima, Lavertu, Marc, Alameh, Mohamad-Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708925/
https://www.ncbi.nlm.nih.gov/pubmed/34960236
http://dx.doi.org/10.3390/vaccines9121490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708925/
https://www.ncbi.nlm.nih.gov/pubmed/34960236
http://dx.doi.org/10.3390/vaccines9121490

Ejemplares similares